Provided by Tiger Fintech (Singapore) Pte. Ltd.

Akari Therapeutics PLC

1.43
+0.0000
Volume:872.00
Turnover:1.24K
Market Cap:41.29M
PE:-0.58
High:1.43
Open:1.43
Low:1.43
Close:1.43
Loading ...

Akari Therapeutics Appoints Mark F. Kubik as Head of Business Development - Oncology

THOMSON REUTERS
·
1 hour ago

Press Release: Akari Therapeutics Appoints Mark F. Kubik as Head of Business Development - Oncology

Dow Jones
·
1 hour ago

European Equities Traded in the US as American Depositary Receipts Higher in Monday Trading

MT Newswires Live
·
28 Apr

European Equities Traded in the US as American Depositary Receipts Rise Sharply in Tuesday Trading

MT Newswires Live
·
22 Apr

Akari Therapeutics Releases Welcome Video From Newly Appointed Chief Executive Officer, Abizer Gaslightwala

THOMSON REUTERS
·
22 Apr

Press Release: Akari Therapeutics Releases Welcome Video from Newly Appointed Chief Executive Officer, Abizer Gaslightwala

Dow Jones
·
22 Apr

European Equities Traded in the US as American Depositary Receipts Modestly Higher in Thursday Trading

MT Newswires Live
·
17 Apr

Akari Therapeutics FY24 Net Loss From Operations $21.6M vs $16.8M YoY

Benzinga
·
16 Apr

Press Release: Akari Therapeutics Reports Full Year 2024 Financial Results and Provides Corporate Update

Dow Jones
·
16 Apr

European Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading

MT Newswires Live
·
08 Apr

European Equities Traded in the US as American Depositary Receipts Drop in Monday Trading

MT Newswires Live
·
07 Apr

European Equities Traded in the US as American Depositary Receipts Tread Water in Tuesday Trading

MT Newswires Live
·
01 Apr

European Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading

MT Newswires Live
·
25 Mar

European Equities Traded in the US as American Depositary Receipts Trend Lower in Thursday Trading

MT Newswires Live
·
20 Mar

Akari Therapeutics Names Abizer Gaslightwala CEO

MT Newswires Live
·
20 Mar

Akari Therapeutics appoints Gaslightwala as CEO

TIPRANKS
·
20 Mar

Akari Therapeutics Appoints Biotechnology Industry Leader, Abizer Gaslightwala, as President and Chief Executive Officer

THOMSON REUTERS
·
20 Mar

Akari Therapeutics Plc - Current President and CEO Samir Patel to Remain as Board Member

THOMSON REUTERS
·
20 Mar

Press Release: Akari Therapeutics Appoints Biotechnology Industry Leader, Abizer Gaslightwala, as President and Chief Executive Officer

Dow Jones
·
20 Mar

European Equities Traded in the US as American Depositary Receipts Track Lower in Wednesday Trading

MT Newswires Live
·
19 Mar